Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

American Renal Associates Holdi (ARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 208,109
  • Shares Outstanding, K 32,517
  • Annual Sales, $ 745,110 K
  • Annual Income, $ 4,860 K
  • 60-Month Beta 2.01
  • Price/Sales 0.25
  • Price/Cash Flow 3.14
  • Price/Book 2.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -90.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.48 +16.79%
on 04/17/19
10.16 -37.01%
on 03/19/19
-3.43 (-34.89%)
since 03/18/19
3-Month
5.48 +16.79%
on 04/17/19
14.10 -54.63%
on 03/01/19
-6.31 (-49.65%)
since 01/18/19
52-Week
5.48 +16.79%
on 04/17/19
23.99 -73.32%
on 08/23/18
-10.33 (-61.75%)
since 04/18/18

Most Recent Stories

More News
AMERICAN RENAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 27, 2019 to file lead plaintiff ...

ARA : 6.40 (+6.67%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against American Renal Associates Holdings, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcomingMay 28, 2019deadline to file a lead plaintiff motion in the class action filed on behalf of American Renal Associates...

ARA : 6.40 (+6.67%)
SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request...

ARA : 6.40 (+6.67%)
CORT : 11.96 (+0.25%)
AVEO : 1.01 (-8.18%)
MBT : 8.09 (+1.13%)
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA) from August 10, 2016 through...

ARA : 6.40 (+6.67%)
ARA CLASS ACTION REMINDER: Hagens Berman Reminds American Renal Associates Holdings (ARA) Investors of Securities Class Action, Encourages Investors With Losses to Contact the Firm

Hagens Berman Sobol Shapiro LLP reminds investors in American Renal Associates Holdings, Inc. (NYSE: ARA) of the pending securities class action and the May 28, 2019 Lead Plaintiff deadline. If you purchased...

ARA : 6.40 (+6.67%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of American Renal Associates Holdings, Inc. - ARA

Pomerantz LLP is investigating claims on behalf of investors of American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA). Such investors are advised to contact Robert...

ARA : 6.40 (+6.67%)
MBT, HCSG & ARA - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

ARA : 6.40 (+6.67%)
MBT : 8.09 (+1.13%)
HCSG : 34.56 (+2.22%)
CLASS ACTION UPDATE for CAG, HCSG, ARA and ZGNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

ARA : 6.40 (+6.67%)
CAG : 30.52 (+1.33%)
HCSG : 34.56 (+2.22%)
ZGNX : 36.17 (-0.88%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In American Renal Associates Holdings, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in American Renal Associates Holdings, Inc. ("American Renal" or the "Company")(NYSE:ARA) of the May 28, 2019 deadline to...

ARA : 6.40 (+6.67%)
INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines - CORT, HCSG, ARA and AMRS

Kaskela Law LLC announces that shareholder class action lawsuits have been filed against Corcept Therapeutics Incorporated (Nasdaq: CORT), Healthcare Services Group, Inc. (Nasdaq: HCSG), American Renal...

ARA : 6.40 (+6.67%)
CORT : 11.96 (+0.25%)
AMRS : 5.02 (+20.10%)
HCSG : 34.56 (+2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARA with:

Business Summary

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 6.95
1st Resistance Point 6.67
Last Price 6.40
1st Support Level 5.97
2nd Support Level 5.55

See More

52-Week High 23.99
Fibonacci 61.8% 16.92
Fibonacci 50% 14.73
Fibonacci 38.2% 12.55
Last Price 6.40
52-Week Low 5.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar